Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
A Thibault, D Samid, A C Tompkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2011
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
A Gronchi, B N Bui, S Bonvalot, et al.
Blood
|
May 23, 2001
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial
J E Karp, J E Lancet, S H Kaufmann, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
A Thibault, D Samid, A C Tompkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2011
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
A Gronchi, B N Bui, S Bonvalot, et al.
Blood
|
May 23, 2001
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial
J E Karp, J E Lancet, S H Kaufmann, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
Page
of 5